Cargando…
Antigen processing and presentation in cancer immunotherapy
BACKGROUND: Knowledge about and identification of T cell tumor antigens may inform the development of T cell receptor-engineered adoptive cell transfer or personalized cancer vaccine immunotherapy. Here, we review antigen processing and presentation and discuss limitations in tumor antigen predictio...
Autores principales: | Lee, Maxwell Y, Jeon, Jun W, Sievers, Cem, Allen, Clint T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454179/ https://www.ncbi.nlm.nih.gov/pubmed/32859742 http://dx.doi.org/10.1136/jitc-2020-001111 |
Ejemplares similares
-
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021) -
Determining if T cell antigens are naturally processed and presented on HLA class I molecules
por: Friedman, Jay, et al.
Publicado: (2022) -
The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
por: Mpakali, Anastasia, et al.
Publicado: (2021) -
An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2022) -
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
por: Thibodeau, Jacques, et al.
Publicado: (2012)